Skip to content

HemodynamIc eFfects of Lung Collapse and overdIstension During ARDS

HemodynamIc eFfects of Lung Collapse and overdIstension in Patients With Moderate-to-seVEre Acute Respiratory Distress Syndrome: the HI-FIVE Physiologic Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07423520
Acronym
HI-FIVE
Enrollment
20
Registered
2026-02-20
Start date
2026-02-28
Completion date
2027-05-01
Last updated
2026-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AHRF, ARDS

Keywords

ARDS, AHRF, acute respiratory distress syndrome, PEEP, collapse, overdistention, hemodynamics, heart-lung interactions, mechanical ventilation, randomized crossover trial

Brief summary

The management ARDS relies on ventilatory strategies aimed at limiting ventilator-induced lung injury (VILI). The setting of PEEP is still subject of debate, as randomized clinical trials comparing standardized higher versus lower PEEP strategies failed to demonstrate a clear survival advantage. Only few studies explored the hemodynamic effects of various PEEP levels depending on lung recruitability. Furthermore, the role of PEEP-mediated lung collapse and overdistention on patients' hemodynamics has yet to be elucidated. In this physiologic study, the association between EIT-measured lung collapse and overdistention and cardiac function will be explored, accounting for the individual potential for lung recruitment, partitioned respiratory mechanics and cardiac preload responsiveness. Three PEEP levels will be tested in a randomized, crossover fashion: PEEP corresponding to the crossing point between lung collapse and overdistention, PEEP associated with low lung collapse, PEEP associated with low lung overdistention.

Interventions

Patients will undergo a decremental PEEP trial to determine the crossing-point PEEP. Secondly, three PEEP levels (low collapse PEEP, low overdistention PEEP and crossing point between lung collapse and overdistention PEEP) will be compared in a randomized order with 30-minute steps

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Randomized crossover trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* acute respiratory failure with onset \< 1 week from a predisposing risk factor, such as pneumonia, non-pulmonary infection, trauma, transfusion, aspiration, or shock; * bilateral opacities on chest radiography and computed tomography or bilateral B lines and/or consolidations on lung ultrasound not fully explained by effusions, atelectasis, or nodules/masses; * pulmonary edema not exclusively or primarily attributable to cardiogenic pulmonary edema/fluid overload, and hypoxemia/gas exchange abnormalities not primarily attributable to atelectasis; * PaO2/FiO2 ratio ≤ 200 during invasive controlled mechanical ventilation;

Exclusion criteria

* age \<18 years; * pregnancy; * signs of barotrauma or documented pneumothorax; * severe tachycardia (HR \> 120 bpm) and severe lacticaemia (lac \> 4 mmol/L) * pre-existing decompensated heart failure (NYHA class 3-4 and/or documented left ventricular ejection fraction \< 35%); * contraindications to EIT placing (open chest wounds, presence of cardiac pacemaker); * intubation as a result of an acute exacerbation of chronic pulmonary disease; * contraindications to esophageal balloon placement (high bleeding risk, esophageal varices).

Design outcomes

Primary

MeasureTime frameDescription
Impact of lung collapse on cardiac outputAssesment performed at the end of each of the three 30 minute stepsEvaluation of the relative contribution of lung collapse (arbitrary units) on patients' cardiac output at different PEEP levels (L/min)
Impact of lung collapse on pulmonary vascular resistanceAssesment performed at the end of each of the three 30 minute stepsEvaluation of the relative contribution of lung collapse (arbitrary units) on pulmonary vascular resistance (dyn·s/cm\^5) at different PEEP levels
Impact of lung overdistention on cardiac outputAssesment performed at the end of each of the three 30 minute stepsEvaluation of the relative contribution of lung overdistention (arbitrary units) on patients' cardiac output at different PEEP levels (L/min)
Impact of lung overdistention on pulmonary vascular resistanceAssesment performed at the end of each of the three 30 minute stepsEvaluation of the relative contribution of lung overdistention (arbitrary units) on pulmonary vascular resistance (dyn·s/cm\^5) at different PEEP levels

Secondary

MeasureTime frameDescription
Correlation between potential for lung recruitment and PEEP-induced changes in cardiac outputAssessment at the end of each of the three 30 minute stepsThe effects of PEEP on cardiac output (mL/min) will be correlated through Pearson correlations with the individual potential for lung recruitment, as determined by the recruitment-to-inflation ratio (R/I)
Correlation between potential for lung recruitment and PEEP-induced changes in pulmonary vascular resistanceAssesment performed at the end of each of the three 30 minute stepsThe effects of PEEP on pulmonary vascular resistance (dyn·s/cm\^5) will be correlated through Pearson correlations with the individual potential for lung recruitment, as determined by the recruitment-to-inflation ratio (R/I)
PEEP-induced effects on cardiac output in cardiac preload responsive vs. nonresponsive patientsAssesment performed at the end of each of the three 30 minute stepsThe effects of PEEP on cardiac output (L/min) will be compared through subgroup comparisons (student t-test) in patients who are preload responsive and patients who are not (preload responsiveness assessed through pulse-pressure variation, expressed in %)
PEEP-induced effects on pulmonary vascular resistance in cardiac preload responsive vs. nonresponsive patientsAssesment performed at the end of each of the three 30 minute stepsThe effects of PEEP on pulmonary vascular resistance (dyn·s/cm\^5) will be compared through subgroup comparisons (student t-test) in patients who are preload responsive and patients who are not (preload resposnsiveness assessed through pulse-pressure variation, expressed in %)
Relationship between transpulmonary pressures and central venous pressure variationsAt the end of each of the three 30 minute stepsThe relationship between transpulmonary pressure variations (cmH2O) and central venous pressure variations (cmH2O) between PEEP levels will be assessed through Pearson correlations
Lung hysteresisAt the end of each of the three 30 minute stepsLung hysteresis will be assessed at each of the tested PEEP levels and expressed as the area of the pressure-volume loop of the respiratory system obtained with a low-flow inflation/deflation maneuver from PEEP to a pressure of 30 cmH2O, in mL\*cmH2O
Lung aeration distributionAt the end of each of the three 30 minute stepsLung aeration distribution at each PEEP level tested will be assessed with electrical impedance tomography (EIT) and expressed as dorsal fraction of ventilation (% of total tidal volume)
Relationship between PEEP-induced changes in lung volume and PEEP-induced changes in pulmonary vascular resistanceAssesment performed at the end of each of the three 30 minute stepsThe effects of PEEP on pulmonary vascular resistance (dyn·s/cm\^5) will be correlated through Pearson correlations with the individual PEEP-induced changes in lung volume (mL)
Relationship between PEEP-induced changes in lung volume and PEEP-induced changes in cardiac outputAssesment performed at the end of each of the three 30 minute stepsThe effects of PEEP cardiac output (L/min) will be correlated through Pearson correlations with the individual PEEP-induced changes in lung volume (mL)

Countries

Italy

Contacts

CONTACTDomenico Luca Grieco, MD
dlgrieco@outlook.it+393397681623
PRINCIPAL_INVESTIGATORDomenico Luca Grieco, MD

Fondazione Policlinico Universitario A. Gemelli, IRCCS

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026